Liver hormone reduces preference for sweets, alcohol, via brain's reward pathway

December 24, 2015

DALLAS - December 24, 2015 -A liver hormone works via the brain's reward pathway to reduce cravings for sweets and alcohol in mammals, UT Southwestern Medical Center researchers have found.

"This is the first time a hormone made in the liver has been shown to affect sugar and alcohol preference in mammals," said Dr. Steven Kliewer, Professor of Molecular Biology and Pharmacology at UT Southwestern and co-senior author of the study, published online today in Cell Metabolism.

The hormone - fibroblast growth factor 21, or FGF21 - is associated with environmental stress such as extreme dietary changes or cold temperature exposure. It is also produced when mammals consume carbohydrates. Because of FGF21's unique effects, forms of the protein are being evaluated as drugs for the treatment of obesity and type 2 diabetes.

"Our findings raise the possibility that FGF21 administration could affect nutrient preference and other reward behaviors in humans, and that the hormone could potentially be used to treat alcoholism," said Dr. Kliewer, who holds the Nancy B. and Jake L. Hamon Distinguished Chair in Basic Cancer Research.

The researchers report that mice with elevated levels of FGF21 showed reduced preference for sweetener- and alcohol-laced water as well as a marked decrease in levels of dopamine, a neurotransmitter that plays a central role in reward behavior.

"We found that FGF21 administration markedly reduces sweet and alcohol preference in mice, and sweet preference in larger animal models," said co-senior author Dr. David Mangelsdorf, Chair of the Department of Pharmacology and a Howard Hughes Medical Institute Investigator, who runs a joint laboratory with Dr. Kliewer. Dr. Mangelsdorf holds the Alfred G. Gilman Distinguished Chair in Pharmacology, and the Raymond and Ellen Willie Distinguished Chair in Molecular Neuropharmacology in Honor of Harold B. Crasilneck, Ph.D.

To confirm that FGF21 acts via a brain pathway, the researchers took advantage of the fact that FGF21 requires the co-receptor β-Klotho in order to function. When FGF21 levels were increased in mice genetically unable to make β-Klotho in the central nervous system, the effect on taste preference disappeared.

This marks the fourth study from the Mangelsdorf-Kliewer laboratory to show that FGF21 directly affects the central nervous system. First, in two studies in Nature Medicine in 2013, they reported on FGF21's ability to regulate metabolism, circadian (body clock) behavior, and female reproduction. In 2014, they reported in Cell Metabolism that FGF21 acts on the brain to cause weight loss.

"The finding that FGF21 acts via the brain was completely unexpected when we started down this path of investigation a dozen years ago," Dr. Kliewer said. "These findings suggest that additional studies are warranted to assess the effects of FGF21 on sweet and alcohol preference and other reward behavior in humans."
-end-
The study was supported by the National Institutes of Health, the Robert A. Welch Foundation, the Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society, the Ford Foundation Fellowship, the German National Science Foundation, and the Howard Hughes Medical Institute. Novo Nordisk provided the recombinant FGF21 used in the experiments.

UT Southwestern co-authors from Pharmacology included Dr. Bryn Owen, a former postdoctoral researcher now at Imperial College, London; Dr. Parkyong Song, a postdoctoral researcher; graduate student Genaro Hernandez; Dr. Yuan Zhang, Instructor in Pharmacology; and summer intern William T. Scott. Also contributing was Dr. Hao Tang, Assistant Professor of Clinical Sciences.

UT Southwestern collaborated on the study with researchers from Friedrich-Alexander University Erlangen-Nuremberg in Germany, King's College London in England, and Pfizer in the United States.

About UT Southwestern Medical Center

UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including six who have been awarded Nobel Prizes since 1985. The faculty of more than 2,700 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to about 92,000 hospitalized patients and oversee approximately 2.1 million outpatient visits a year.

UT Southwestern Medical Center

Related Alcohol Articles from Brightsurf:

Alcohol use changed right after COVID-19 lockdown
One in four adults reported a change in alcohol use almost immediately after stay-at-home orders were issued: 14% reported drinking more alcohol and reported higher levels of stress and anxiety than those who did not drink and those whose use stayed the same.

Changes in hospitalizations for alcohol use disorder in US
Changes over nearly two decades in the rate of hospitalizations and in-hospital deaths from alcohol use disorder in the US were examined in this study.

Associations of alcohol consumption, alcohol-induced passing out with risk of dementia
The risk of future dementia associated with overall alcohol consumption and alcohol-induced loss of consciousness in a population of current drinkers was examined in this observational study with more than 131,000 adults.

New alcohol genes uncovered
Do you have what is known as problematic alcohol use?

Does estrogen influence alcohol use disorder?
A new study from researchers at the University of Illinois at Chicago shows that high estrogen levels may make alcohol more rewarding to female mice.

Sobering new data on drinking and driving: 15% of US alcohol-related motor vehicle fatalities involve alcohol under the legal limit
A new study in the American Journal of Preventive Medicine, published by Elsevier, found that motor vehicle crashes involving drivers with blood alcohol concentrations (BACs) below the legal limit of 0.08 percent accounted for 15% of alcohol-involved crash deaths in the United States.

Alcohol-induced deaths in US
National vital statistics data from 2000 to 2016 were used to examine how rates of alcohol-induced deaths (defined as those deaths due to alcohol consumption that could be avoided if alcohol weren't involved) have changed in the US and to compare the results by demographic groups including sex, race/ethnicity, age, socioeconomic status and geographic location.

Cuts in alcohol duty linked to 2000 more alcohol-related deaths in England
Government cuts to alcohol taxes have had dramatic consequences for public health, including nearly 2000 more alcohol-related deaths in England since 2012, according to new research from the University of Sheffield's School of Health and Related Research (ScHARR).

Integrated stepped alcohol treatment for people in HIV care improves both HIV & alcohol outcomes
Increasing the intensity of treatment for alcohol use disorder (AUD) over time improves alcohol-related outcomes among people with HIV, according to new clinical research supported by the National Institutes of Health.

The Lancet:Targets to reduce harmful alcohol use are likely to be missed as global alcohol intake increases
Increasing rates of alcohol use suggest that the world is not on track to achieve targets against harmful alcohol use, according to a study of 189 countries' alcohol intake between 1990-2017 and estimated intake up to 2030, published in The Lancet.

Read More: Alcohol News and Alcohol Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.